Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease.
Study Details
Study Description
Brief Summary
This study will compare smartphone usage data between three groups of patients diagnosed with either a memory complaint, mild cognitive decline, or Alzheimer's disease.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Alzheimer's disease (AD) is the leading cause of dementia in the world. The first cognitive function affected is memory and then other cognitive systems are affected leading to a progressive loss of autonomy of the patient. Currently, the diagnosis of AD is made at too late a stage. Patients with memory complaints or mild cognitive decline (MCI) are particularly at risk of developing AD.
However, there is no clinical or paraclinical evidence to predict precisely this risk of progression to AD. Our hypothesis is that there is an association between the evolution of smartphone use and the conversion of cognitive status to AD.
The purpose of this pilot study is to identify existing differences between smartphone use data of patients with a memory complaint or of patients MCI or with an AD. It is a study of 90 patients (30 patients with memory complaint, 30 with MCI and 30 with AD) with a collection of smartphone usage data during three months.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Memory complaint
|
Other: recording of smartphone usage data
recording of smartphone usage data
|
Other: mild cognitive decline
|
Other: recording of smartphone usage data
recording of smartphone usage data
|
Other: Alzheimer's Disease
|
Other: recording of smartphone usage data
recording of smartphone usage data
|
Outcome Measures
Primary Outcome Measures
- Comparison of a mathematical combination [up to three months]
the comparison of a mathematical combination of the different parameters collected during the three months of smartphone data recording
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient consulting in routine care in one of the CMRR
-
No sensory impairment that may compromise smartphone use
Exclusion Criteria:
-
Inability to perform MMSE or MMSE < 20 ;
-
Other neurodegenerative condition (Parkinson's disease, Lewy body disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis)
-
Severe anxiety or depressive disorder HADS score ≥ 17
-
Terminal phase of a severe disease
-
Evidence of a lesion on MRI that may be involved in cognitive impairment
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | CHU Poitiers | Poitiers | France | 86000 |
Sponsors and Collaborators
- Poitiers University Hospital
- Xlim laboratory
Investigators
- Principal Investigator: JULIAN Adrien, Poitiers University Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IMASMART